E. J. Adams, S. Gu, and A. M. Luoma, Human gamma delta T cells: Evolution and ligand recognition, Cellular immunology, vol.296, pp.31-40, 2015.

D. Kabelitz, T-cells: cross-talk between innate and adaptive immunity. Cellular and molecular life sciences : CMLS 68, pp.2331-2334, 2011.

P. Vantourout and A. Hayday, Six-of-the-best: unique contributions of gammadelta T cells to immunology, Nature reviews. Immunology, vol.13, pp.88-100, 2013.

F. Bouet-toussaint, F. Cabillic, O. Toutirais, and M. Le-gallo,

C. Pintiere, P. Daniel, N. Genetet, B. Meunier, E. Dupont-bierre et al., Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas, Cancer immunology, immunotherapy : CII, vol.57, pp.531-540, 2008.

A. Cordova, F. Toia, C. La-mendola, V. Orlando, S. Meraviglia et al.,

M. Todaro, G. Cicero, L. Zichichi, P. L. Donni, N. Caccamo et al., Characterization of human gammadelta T lymphocytes infiltrating primary malignant melanomas, PloS one, vol.7, p.49878, 2012.

M. Corvaisier, A. Moreau-aubry, E. Diez, J. Bennouna, and J. F. Mosnier,

E. Scotet, M. Bonneville, and F. Jotereau, V gamma 9V delta 2 T cell response to colon carcinoma cells, Journal of immunology, vol.175, pp.5481-5489, 2005.

S. Meraviglia, M. Eberl, D. Vermijlen, M. Todaro, S. Buccheri et al.,

L. Mendola, C. Guggino, G. D'asaro, M. Orlando, V. Scarpa et al., Targeting gammadelta T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application, Cancer research, vol.70, pp.10024-10031, 2010.

M. Tosolini, F. Pont, M. Poupot, F. Vergez, and M. L. Nicolau-travers,

D. Vermijlen, J. E. Sarry, F. Dieli, and J. J. Fournie, Assessment of tumorinfiltrating TCRVgamma9Vdelta2 gammadelta lymphocyte abundance by deconvolution of human cancers microarrays, Oncoimmunology, vol.6, p.1284723, 2017.

V. Groh, A. Steinle, S. Bauer, and T. Spies, Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells, Science, vol.279, pp.1737-1777, 1998.

F. M. Spada, E. P. Grant, P. J. Peters, M. Sugita, A. Melian et al.,

H. K. Lee, E. Van-donselaar, D. A. Hanson, A. M. Krensky, O. Majdic et al., Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity, The Journal of experimental medicine, vol.191, pp.937-985, 2000.

L. Bai, D. Picard, B. Anderson, V. Chaudhary, A. Luoma et al., The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vdelta1 TCR, European journal of immunology, vol.42, pp.2505-2515, 2012.

A. P. Uldrich, J. Le-nours, D. G. Pellicci, N. A. Gherardin, and K. Mcpherson,

G. Lim, R. T. Patel, O. Beddoe, T. Gras, S. Rossjohn et al., , 2013.

, CD1d-lipid antigen recognition by the gammadelta TCR, Nature immunology, vol.14, pp.1137-1182

X. Zeng, Y. L. Wei, J. Huang, E. W. Newell, H. Yu et al.,

S. Waters, R. W. Davis, M. M. Weaver, C. T. Chien, and Y. H. , , p.39, 2012.

D. Daley, C. P. Zambirinis, L. Seifert, N. Akkad, N. Mohan et al.,

R. Barilla, A. Torres-hernandez, M. Hundeyin, V. R. Mani, A. Avanzi et al., ) gammadelta T Cells Support Pancreatic Oncogenesis by Restraining alphabeta T Cell Activation, e15. 40. Barjon, vol.166, pp.1485-1499, 2016.

A. Gennetier, F. Sanchez, L. Gros, J. F. Eliaou, N. Bonnefoy et al., , 2017.

J. Bastid, A. Regairaz, N. Bonnefoy, C. Dejou, J. Giustiniani et al.,

S. Cochaud, E. Laprevotte, E. Funck-brentano, P. Hemon, L. Gros et al., Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity, Cancer immunology research, vol.3, pp.254-65, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02188752

R. Salgado, C. Denkert, S. Demaria, N. Sirtaine, F. Klauschen et al.,

S. Wienert, G. Van-den-eynden, F. L. Baehner, F. Penault-llorca, E. A. Perez et al.,

H. Bailey, M. Ignatiadis, G. Floris, J. Sparano, Z. Kos et al., The evaluation of tumorinfiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group, Annals of oncology : official journal of the European Society for Medical Oncology, vol.26, pp.259-71, 2014.

H. Yano, L. P. Andrews, C. J. Workman, and D. A. Vignali, Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity, Immunology, vol.157, pp.232-247, 2019.

D. J. Waugh and C. Wilson, The interleukin-8 pathway in cancer, 2008.

, Clinical cancer research : an official journal of the American Association for Cancer Research, vol.14, pp.6735-6776

K. Xie, Interleukin-8 and human cancer biology, Cytokine & growth factor reviews, vol.12, pp.375-91, 2001.

C. Ma, Q. Zhang, J. Ye, F. Wang, Y. Zhang et al.,

P. Hunborg, M. A. Varvares, D. F. Hoft, E. C. Hsueh, and G. Peng, , 2012.

M. R. Elliott, F. B. Chekeni, P. C. Trampont, E. R. Lazarowski, A. Kadl et al., Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance, Nature, vol.461, pp.282-288, 2009.

L. Aymeric, L. Apetoh, F. Ghiringhelli, A. Tesniere, I. Martins et al.,

M. J. Smyth and L. Zitvogel, Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity, Cancer research, vol.70, pp.855-863, 2010.

C. Silva-vilches, S. Ring, and K. Mahnke, , 2018.

, Adenosine as Regulators of Dendritic Cell Activity, Trends in pharmacological sciences, vol.9, pp.211-218, 2006.

M. Oft, IL-10: master switch from tumor-promoting inflammation to antitumor immunity, Cancer immunology research, vol.2, pp.194-203, 2014.

A. Janssen, J. Villacorta-hidalgo, D. X. Beringer, and S. Van-dooremalen,

F. Fernando, E. Van-diest, A. R. Terrizi, P. Bronsert, S. Kock et al.,

S. A. Kasatskaya, F. E. Frenkel, S. Ravens, E. Spierings, I. Prinz et al., 2020) gammadelta T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity, Cancer immunology research

Y. Wu, F. Kyle-cezar, R. T. Woolf, C. Naceur-lombardelli, and J. Owen,

D. Biswas, A. Lorenc, P. Vantourout, P. Gazinska, A. Grigoriadis et al., An innate-like Vdelta1(+) gammadelta T cell compartment in the human breast is associated with remission in triple-negative breast cancer, p.11, 2019.

G. Pizzolato, H. Kaminski, M. Tosolini, D. M. Franchini, F. Pont et al.,

C. Valle, D. Labourdette, S. Cadot, A. Quillet-mary, M. Poupot et al.,

L. Ysebaert, S. Meraviglia, F. Dieli, P. Merville, P. Milpied et al.,

J. J. Fournie, Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVdelta1 and TCRVdelta2 gammadelta T lymphocytes, Proceedings of the National Academy of Sciences of the United States of America, vol.116, pp.11906-11915, 2019.

M. R. Bono, D. Fernandez, F. Flores-santibanez, M. Rosemblatt, and D. Sauma, CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression, FEBS letters, vol.589, pp.3454-60, 2015.

K. Wistuba-hamprecht, A. Martens, K. Haehnel, M. Geukes-foppen, J. Yuan et al., Proportions of blood-borne Vdelta1+ and Vdelta2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab, European journal of cancer, vol.64, pp.116-142, 2016.

L. N. Wang, Y. X. Cui, F. Ruge, and W. G. Jiang, Interleukin 21 and Its Receptor Play a Role in Proliferation, Migration and Invasion of Breast Cancer Cells, Cancer genomics & proteomics, vol.12, pp.211-232, 2015.